Evidence map›Paper›PMID 27398087›Full record

ArticleAIDS research and therapy2016

Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.

Jeremy Philip Brown, Bagrey Ngwira, Terence Tafatatha, Amelia Catharine Crampin, Neil French, Olivier Koole

Open access · goldAbstract read
In one paragraph

Article in AIDS research and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jeremy Philip BrownLondon School of Hygiene and Tropical Medicine, London, UK.
Bagrey NgwiraLondon School of Hygiene and Tropical Medicine, London, UK ; Karonga Prevention Study, Chilumba, Malawi.
Terence TafatathaKaronga Prevention Study, Chilumba, Malawi ; Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, UK.
Amelia Catharine CrampinLondon School of Hygiene and Tropical Medicine, London, UK ; Karonga Prevention Study, Chilumba, Malawi.
Neil FrenchLondon School of Hygiene and Tropical Medicine, London, UK ; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Olivier KooleLondon School of Hygiene and Tropical Medicine, London, UK ; Karonga Prevention Study, Chilumba, Malawi.ORCID 0000-0002-1122-5382
London School of Hygiene & Tropical Medicine · GBLiverpool School of Tropical Medicine · GB

Funding

Wellcome Trust 098610Wellcome Trust 101594Wellcome Trust WT079827Wellcome Trust WT096249
6 · The paper itself

Abstract

backgroundTo optimise care HIV patients need to be promptly initiated on antiretroviral therapy (ART) and subsequently retained on treatment. In this study we report on the interval between enrolment and treatment initiation, and investigate subsequent attrition and mortality of patients on ART at a rural clinic in Malawi.

methodsHIV-positive individuals were recruited to a cohort study between January 2008 and August 2011 at Chilumba Rural Hospital (CRH). Outcomes were ascertained, up to 7 years after enrolment, through follow-up and by linkage to ART registers and the Karonga Health and Demographic Surveillance System (KHDSS). Kaplan-Meier methods and Cox regression were used to examine ART initiation after enrolment, mortality after ART initiation, and attrition after ART initiation.

resultsOf the 617 individuals recruited, 523 initiated ART between January 2008 and January 2015. Median time from HIV testing to commencement of ART was 59 days (IQR: 10-330). By a year after enrolment 74.2 % (95 % CI 70.6-77.7 %) had initiated ART. Baseline clinical data at ART initiation and data on attrition was only available for the 438 individuals who initiated ART during active follow-up, between January 2008 and August 2011. Of these individuals, 6 were missing Ministry of Health numbers, leaving 432 included in analyses of attrition and mortality. At 4 years after ART initiation 71.3 % (95 % CI 65.7-76.2 %) of these patients were retained on treatment at the CRH and 17.2 % (95 % CI 13.8-21.4 %) had died. Participants who had a lower CD4 count at enrolment (≤350 cells/μl), enrolled in 2008, or tested for HIV at the CRH rather than through serosurveys, initiated treatment faster. Once on treatment, mortality rates were higher in patients who were HIV tested at the CRH, male, older (≥35 years), missing a CD4 count, or underweight (BMI < 18.5) at ART initiation.

conclusionsThrough linkage to the KHDSS and ART registers it was possible to continue follow-up beyond the end of the initial cohort study. Annual mortality after ART initiation remained considerable over a period of 4 years. Greater access to HIV and CD4 testing alongside initiation at higher CD4 counts, as planned in the test and treat strategy, could reduce this mortality.

Indexed as

AdolescentAdultAnti-HIV AgentsCD4 Lymphocyte CountDelayed DiagnosisFemaleHIV InfectionsHumansKaplan-Meier EstimateLost to Follow-UpMalawiMaleProportional Hazards ModelsRural PopulationTime FactorsYoung AdultAnti-HIV AgentsARTAttritionCD4 countHIVHIV testingMalawiMortalitySub-Saharan Africa

Identifiers

PMID27398087
PMCPMC4938927
OpenAlexW2473829115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.